FDG-PET Positivity and Overall Survival in Renal Cell Carcinoma

JAMA Netw Open. 2022 Nov 1;5(11):e2242289. doi: 10.1001/jamanetworkopen.2022.42289.

Authors

Justin Ferdinandus¹, Ines Maríc¹, Christopher Darr², Claudia Kesch², Timo Bartel¹, Wolfgang Peter Fendler¹, Viktor Grünwald^{2

3}

Affiliations

¹ Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
² Department of Urology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
³ Department of Medical Oncology, Department of Medical Oncology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

No abstract available

Plain language summary

This cohort study examines positron emission tomography in renal cell carcinoma and its association with overall survival among adults.

MeSH terms

Carcinoma, Renal Cell* / diagnostic imaging
Fluorodeoxyglucose F18
Humans
Kidney Neoplasms* / diagnostic imaging
Kidney Neoplasms* / pathology
Positron-Emission Tomography

Substances

Fluorodeoxyglucose F18